Literature DB >> 25375919

Reply to Colorectal cancer classification based on gene expression is not associated with FOLFIRI response.

Anguraj Sadanandam1, Joe Gray2, Douglas Hanahan3.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25375919     DOI： 10.1038/nm.3742

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  7 in total

1.  Improved survival with vemurafenib in melanoma with BRAF V600E mutation.

Authors:  Paul B Chapman; Axel Hauschild; Caroline Robert; John B Haanen; Paolo Ascierto; James Larkin; Reinhard Dummer; Claus Garbe; Alessandro Testori; Michele Maio; David Hogg; Paul Lorigan; Celeste Lebbe; Thomas Jouary; Dirk Schadendorf; Antoni Ribas; Steven J O'Day; Jeffrey A Sosman; John M Kirkwood; Alexander M M Eggermont; Brigitte Dreno; Keith Nolop; Jiang Li; Betty Nelson; Jeannie Hou; Richard J Lee; Keith T Flaherty; Grant A McArthur
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

2.  Colorectal cancer classification based on gene expression is not associated with FOLFIRI response.

Authors:  Raquel Martinez-Garcia; Pedro P Lopez-Casas; Daniel Rico; Alfonso Valencia; Manuel Hidalgo
Journal:  Nat Med       Date:  2014-11       Impact factor: 53.440

3.  Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Authors:  D J Slamon; B Leyland-Jones; S Shak; H Fuchs; V Paton; A Bajamonde; T Fleming; W Eiermann; J Wolter; M Pegram; J Baselga; L Norton
Journal:  N Engl J Med       Date:  2001-03-15       Impact factor: 91.245

4.  Reconciliation of classification systems defining molecular subtypes of colorectal cancer: interrelationships and clinical implications.

Authors:  Anguraj Sadanandam; Xin Wang; Felipe de Sousa E Melo; Joe W Gray; Louis Vermeulen; Douglas Hanahan; Jan Paul Medema
Journal:  Cell Cycle       Date:  2014-01-09       Impact factor: 4.534

5.  Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan.

Authors:  Maguy Del Rio; Franck Molina; Caroline Bascoul-Mollevi; Virginie Copois; Frédéric Bibeau; Patrick Chalbos; Corinne Bareil; Andrew Kramar; Nicolas Salvetat; Caroline Fraslon; Emmanuel Conseiller; Virginie Granci; Benjamin Leblanc; Bernard Pau; Pierre Martineau; Marc Ychou
Journal:  J Clin Oncol       Date:  2007-03-01       Impact factor: 44.544

6.  A colorectal cancer classification system that associates cellular phenotype and responses to therapy.

Authors:  Anguraj Sadanandam; Costas A Lyssiotis; Krisztian Homicsko; Eric A Collisson; William J Gibb; Stephan Wullschleger; Liliane C Gonzalez Ostos; William A Lannon; Carsten Grotzinger; Maguy Del Rio; Benoit Lhermitte; Adam B Olshen; Bertram Wiedenmann; Lewis C Cantley; Joe W Gray; Douglas Hanahan
Journal:  Nat Med       Date:  2013-04-14       Impact factor: 53.440

7.  Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

Authors:  Alice T Shaw; Dong-Wan Kim; Kazuhiko Nakagawa; Takashi Seto; Lucio Crinó; Myung-Ju Ahn; Tommaso De Pas; Benjamin Besse; Benjamin J Solomon; Fiona Blackhall; Yi-Long Wu; Michael Thomas; Kenneth J O'Byrne; Denis Moro-Sibilot; D Ross Camidge; Tony Mok; Vera Hirsh; Gregory J Riely; Shrividya Iyer; Vanessa Tassell; Anna Polli; Keith D Wilner; Pasi A Jänne
Journal:  N Engl J Med       Date:  2013-06-01       Impact factor: 91.245
  7 in total
  4 in total

1.  Monitoring cancer stem cells: insights into clinical oncology.

Authors:  ShuChen Lin; YingChun Xu; ZhiHua Gan; Kun Han; HaiYan Hu; Yang Yao; MingZhu Huang; DaLiu Min
Journal:  Onco Targets Ther       Date:  2016-02-11       Impact factor: 4.147

Review 2.  Exploring and modelling colon cancer inter-tumour heterogeneity: opportunities and challenges.

Authors:  Joyce Y Buikhuisen; Arezo Torang; Jan Paul Medema
Journal:  Oncogenesis       Date:  2020-07-09       Impact factor: 7.485

Review 3.  Understanding cell-cell communication and signaling in the colorectal cancer microenvironment.

Authors:  Shaikha AlMusawi; Mehreen Ahmed; Abdolrahman S Nateri
Journal:  Clin Transl Med       Date:  2021-02

4.  Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer.

Authors:  Yongjun Cha; Kyung-Ju Kim; Sae-Won Han; Ye Young Rhee; Jeong Mo Bae; Xianyu Wen; Nam-Yun Cho; Dae-Won Lee; Kyung-Hun Lee; Tae-Yong Kim; Do-Youn Oh; Seock-Ah Im; Yung-Jue Bang; Seung-Yong Jeong; Kyu Joo Park; Gyeong Hoon Kang; Tae-You Kim
Journal:  Br J Cancer       Date:  2016-06-16       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.